A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 530,827 shares of ABBV stock, worth $93.9 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
530,827
Previous 522,855 1.52%
Holding current value
$93.9 Million
Previous $89.7 Million 16.89%
% of portfolio
0.47%
Previous 0.45%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $1.31 Million - $1.59 Million
7,972 Added 1.52%
530,827 $105 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $30.9 Million - $36.1 Million
-199,900 Reduced 27.66%
522,855 $89.7 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $19.6 Million - $22.4 Million
122,846 Added 20.48%
722,755 $132 Million
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $6.92 Million - $7.8 Million
50,316 Added 9.16%
599,909 $93 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $3.59 Million - $4.15 Million
26,853 Added 5.14%
549,593 $81.9 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $3.61 Million - $4.49 Million
27,211 Added 5.49%
522,740 $70.4 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $2 Million - $2.3 Million
13,797 Added 2.86%
495,529 $79 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $4.43 Million - $5.31 Million
32,008 Added 7.12%
481,732 $77.9 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $1.95 Million - $2.24 Million
14,541 Added 3.34%
449,724 $60.4 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $14 Million - $17.8 Million
101,821 Added 30.54%
435,183 $66.7 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $1.54 Million - $1.96 Million
-11,186 Reduced 3.25%
333,362 $51.1 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $190,183 - $235,963
1,441 Added 0.42%
344,548 $55.9 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $1.48 Million - $1.87 Million
13,735 Added 4.17%
343,107 $46.5 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.78 Million - $3.16 Million
26,174 Added 8.63%
329,372 $35.5 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $2.56 Million - $2.85 Million
24,306 Added 8.72%
303,198 $34.2 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $4.4 Million - $4.85 Million
43,021 Added 18.24%
278,892 $30.2 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $2.03 Million - $2.75 Million
25,275 Added 12.0%
235,871 $25.3 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $2.2 Million - $2.58 Million
-25,579 Reduced 10.83%
210,596 $18.4 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $4.49 Million - $6.01 Million
61,254 Added 35.02%
236,175 $23.2 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $1.55 Million - $2.35 Million
-24,056 Reduced 12.09%
174,921 $13.3 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $7.33 Million - $9.17 Million
101,580 Added 104.29%
198,977 $17.6 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $489,543 - $588,571
-7,773 Reduced 7.39%
97,397 $7.38 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $168,586 - $215,492
-2,566 Reduced 2.38%
105,170 $7.62 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $228,951 - $269,464
-2,968 Reduced 2.68%
107,736 $8.68 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $373,835 - $461,040
-4,802 Reduced 4.16%
110,704 $10.2 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $2.85 Million - $3.17 Million
32,046 Added 38.4%
115,506 $10.9 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $1.02 Million - $1.2 Million
11,312 Added 15.68%
83,460 $7.73 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $3.55 Million - $4.75 Million
-38,535 Reduced 34.82%
72,148 $6.83 Million
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $1.13 Million - $1.24 Million
12,627 Added 12.88%
110,683 $10.7 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $1.71 Million - $2.18 Million
24,412 Added 33.15%
98,056 $8.71 Million
Q2 2017

Aug 14, 2017

BUY
N/A
73,644
73,644 $5.34 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.